Compare Quest Diagnostics Inc (DGX) vs Home Depot Inc (HD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Home Depot Inc — how do they compare? Quest Diagnostics Inc trades at $202.3 (market cap $22.80B), while Home Depot Inc trades at $341.98 (market cap $336.77B). The key difference: Home Depot Inc is far larger — about 14.8× Quest Diagnostics Inc's market cap, and Home Depot Inc pays the higher dividend (2.76%). Which is the better fit depends on your goals.
| DGX | HD | |
|---|---|---|
Market Cap | $22.80B | $336.77B |
Sector | Health | Consumer Cyclical |
52-Week High | $216.02 | $423.42 |
52-Week Low | $166.42 | $297.51 |
Enterprise Value | $28.82B | $398.32B |
Dividend Yield | 1.67% | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
Home Depot (HD) trades at $341.44, up 1.28% over 24 hours, with technical indicators showing a bearish bias despite recent earnings beats. The stock faces headwinds from weak big-ticket demand and margin pressures, though Pro segment growth and housing tailwinds provide support. Revenue reached $159.51B in 2025 with a net income margin of 8.41%, while valuation metrics like a P/E of 23.99 suggest moderate pricing relative to earnings.
The outlook is mixed: analyst consensus leans bullish with a $370.59 price target, but near-term risks include rising mortgage rates and competitive pressures. Long-term investors may find value in HD's resilient business model and dividend yield, though volatility from macroeconomic factors warrants caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
